HYPASE Trademark
Trademark Overview
On Friday, September 13, 2024, a trademark application was filed for HYPASE with the United States Patent and Trademark Office. The USPTO has given the HYPASE trademark a serial number of 98749357. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, August 4, 2025. This trademark is owned by WUXI BIOLOGICS IRELAND LIMITED. The HYPASE trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:
processing and treating of chemical reagents, namely, the custom manufacture of chemical reagents; custom manufacturing of antibody drugs; processing of biomedical preparations, namely, the custom manufacture of biopharmaceutical preparations; processing of pharmaceutical preparations, namely, the custom manufacture of pharmaceuticals preparations; custom manufacturing of pharmaceuticals; custom manufacture of biopharmaceuticals
Consulting services in the field of technological product development; research and development of new products for others; research and development of new products; scientific research and development; pharmaceutical drug development services; pharmaceutical research services; biochemical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibodies; biomedical research services
General Information
| Serial Number | 98749357 |
| Word Mark | HYPASE |
| Filing Date | Friday, September 13, 2024 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Monday, August 4, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 26, 2025 |
Trademark Statements
| Goods and Services | processing and treating of chemical reagents, namely, the custom manufacture of chemical reagents; custom manufacturing of antibody drugs; processing of biomedical preparations, namely, the custom manufacture of biopharmaceutical preparations; processing of pharmaceutical preparations, namely, the custom manufacture of pharmaceuticals preparations; custom manufacturing of pharmaceuticals; custom manufacture of biopharmaceuticals |
| Goods and Services | Consulting services in the field of technological product development; research and development of new products for others; research and development of new products; scientific research and development; pharmaceutical drug development services; pharmaceutical research services; biochemical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibodies; biomedical research services |
Classification Information
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 13, 2024 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, September 13, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | WUXI BIOLOGICS IRELAND LIMITED |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | COUNTY LOUTH A91X56F
IE |
Trademark Events
| Event Date | Event Description |
| Friday, January 24, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, March 13, 2025 | ASSIGNED TO EXAMINER |
| Friday, September 13, 2024 | NEW APPLICATION ENTERED |
| Monday, March 24, 2025 | NON-FINAL ACTION E-MAILED |
| Monday, March 24, 2025 | NON-FINAL ACTION WRITTEN |
| Monday, March 24, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, June 18, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, June 18, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, July 17, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 20, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, June 18, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
